Reason #1: A Potential Acquisition
In general, one of the primary goals of a strategic alternatives review is to assess the potential for a merger or acquisition. In the case of Neurotrope, this is likely going to be one of the key points of focus during the exploration.
At the end of the day, the company has multiple assets under development that big players in the industry would likely want to get their hands on. Considering the tough position that NTRP is in, a potential suitor could provide a pretty strong premium to current prices and still make out like a bandit on the assets that would come with an acquisition.
Of course, if an acquisition were to take place at a premium, it would offer an immediate return of value for investors.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
Click below to continue reading.